The infectious disease challenges of our time.
作者信息
van der Meer Jos W M
机构信息
Department of Internal Medicine, Nijmegen Instutie for Infection Inflammation and Immunity, Radboud University Nijmegen Medical Centre Nijmegen, Netherlands.
出版信息
Front Public Health. 2013 Mar 22;1:7. doi: 10.3389/fpubh.2013.00007. eCollection 2013.
Abstract
摘要
相似文献
1
The infectious disease challenges of our time.我们这个时代的传染病挑战。
Front Public Health. 2013 Mar 22;1:7. doi: 10.3389/fpubh.2013.00007. eCollection 2013.
2
Basis of science policies for infectious disease challenges in India.印度传染病挑战的科学政策基础。
Indian J Public Health. 2018 Jul-Sep;62(3):193-196. doi: 10.4103/ijph.IJPH_306_17.
3
Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges.新发和被忽视的传染病：见解、进展与挑战
Biomed Res Int. 2017;2017:5245021. doi: 10.1155/2017/5245021. Epub 2017 Feb 13.
4
Identifying climate drivers of infectious disease dynamics: recent advances and challenges ahead.识别传染病动态变化的气候驱动因素：近期进展与未来挑战。
Proc Biol Sci. 2017 Aug 16;284(1860). doi: 10.1098/rspb.2017.0901.
5
The potential of wastewater-based epidemiology as surveillance and early warning of infectious disease outbreaks.基于废水的流行病学在传染病暴发监测和早期预警方面的潜力。
Curr Opin Environ Sci Health. 2020 Oct;17:1-7. doi: 10.1016/j.coesh.2020.04.006. Epub 2020 May 11.
6
Professional challenges and opportunities in clinical microbiology and infectious diseases in Europe.欧洲临床微生物学和传染病领域的专业挑战与机遇。
Lancet Infect Dis. 2011 May;11(5):408-15. doi: 10.1016/S1473-3099(10)70294-2.
7
Perceptions of capacity for infectious disease control and prevention to meet the challenges of dengue fever in the face of climate change: A survey among CDC staff in Guangdong Province, China.应对气候变化下登革热挑战的传染病控制和预防能力认知：中国广东省疾病预防控制中心工作人员调查。
Environ Res. 2016 Jul;148:295-302. doi: 10.1016/j.envres.2016.03.043. Epub 2016 Apr 16.
8
Emerging and reemerging infections. Progress and challenges in the subspecialty of infectious disease pathology.新发和再发感染。传染病病理学亚专业的进展与挑战。
Arch Pathol Lab Med. 1997 Aug;121(8):776-84.
9
Systematic Evolution of Ligands by Exponential Enrichment Technologies and Aptamer-Based Applications: Recent Progress and Challenges in Precision Medicine of Infectious Diseases.基于指数富集技术的配体系统进化及适体应用：传染病精准医学的最新进展与挑战
Front Bioeng Biotechnol. 2021 Aug 10;9:704077. doi: 10.3389/fbioe.2021.704077. eCollection 2021.
10
Infectious Diseases, Urbanization and Climate Change: Challenges in Future China.传染病、城市化与气候变化：中国未来面临的挑战
Int J Environ Res Public Health. 2015 Sep 7;12(9):11025-36. doi: 10.3390/ijerph120911025.
引用本文的文献
1
Cell Membrane-Coated Mimics: A Methodological Approach for Fabrication, Characterization for Therapeutic Applications, and Challenges for Clinical Translation.细胞膜包覆模拟物：用于治疗应用的制造、表征的方法学方法，以及临床转化的挑战。
ACS Nano. 2021 Nov 23;15(11):17080-17123. doi: 10.1021/acsnano.1c03800. Epub 2021 Oct 26.
2
Effect of orally administered combination of and (Aubl) Merr extracts on phagocytic activity of macrophage.口服 和 （奥布）梅里尔提取物组合对巨噬细胞吞噬活性的影响。
Res Pharm Sci. 2020 Aug 28;15(4):401-409. doi: 10.4103/1735-5362.293518. eCollection 2020 Aug.
3
Synergistic Antibacterial Activity of Silver-Loaded Graphene Oxide towards and .载银氧化石墨烯对[具体对象1]和[具体对象2]的协同抗菌活性 。 （你原文中towards后面内容缺失，请补充完整以便我给出更准确译文）
Nanomaterials (Basel). 2020 Feb 20;10(2):366. doi: 10.3390/nano10020366.
本文引用的文献
1
Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans.功能基因组学鉴定出 I 型干扰素途径是宿主防御白念珠菌的核心。
Nat Commun. 2013;4:1342. doi: 10.1038/ncomms2343.
2
Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial.辅助干扰素-γ 免疫疗法治疗 HIV 相关隐球菌性脑膜炎：一项随机对照试验。
AIDS. 2012 Jun 1;26(9):1105-13. doi: 10.1097/QAD.0b013e3283536a93.
3
Society's failure to protect a precious resource: antibiotics.社会未能保护一种珍贵资源：抗生素。
Lancet. 2011 Jul 23;378(9788):369-71. doi: 10.1016/S0140-6736(11)60401-7. Epub 2011 Apr 7.
4
Challenges of antibacterial discovery.抗菌药物发现的挑战。
Clin Microbiol Rev. 2011 Jan;24(1):71-109. doi: 10.1128/CMR.00030-10.
5
Immunotherapy for sepsis--a new approach against an ancient foe.脓毒症的免疫疗法——对抗古老敌人的新方法。
N Engl J Med. 2010 Jul 1;363(1):87-9. doi: 10.1056/NEJMcibr1004371.
6
Antibiotic prescribing in hospitals: a social and behavioural scientific approach.医院抗生素处方：一种社会和行为科学方法。
Lancet Infect Dis. 2010 Mar;10(3):167-75. doi: 10.1016/S1473-3099(10)70027-X.
7
Effect of clarithromycin in patients with sepsis and ventilator-associated pneumonia.克拉霉素对脓毒症合并呼吸机相关性肺炎患者的疗效
Clin Infect Dis. 2008 Apr 15;46(8):1157-64. doi: 10.1086/529439.
8
International sepsis trial (INTERSEPT): role and impact of a clinical evaluation committee.国际脓毒症试验（INTERSEPT）：临床评估委员会的作用与影响
Crit Care Med. 1996 Sep;24(9):1441-7. doi: 10.1097/00003246-199609000-00003.
9
The sepsis syndrome. Definition and general approach to management.脓毒症综合征。定义及一般处理方法。
Clin Chest Med. 1996 Jun;17(2):175-81. doi: 10.1016/s0272-5231(05)70307-5.
10
Correlation between proinflammatory cytokines and antiinflammatory mediators and the severity of disease in meningococcal infections.促炎细胞因子与抗炎介质之间的相关性以及脑膜炎球菌感染中疾病的严重程度。
J Infect Dis. 1995 Aug;172(2):433-9. doi: 10.1093/infdis/172.2.433.
Zotero 插件